Xu-Feng Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xu-Feng Xu has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Yu Qu
Qilu Hospital of Shandong University, Jinan, China
5 shared publicationsXia Zhang
Neuropsychiatry Research Institute, Basic School of Medicine The Affiliated Hospital of Qingdao University Qingdao University Qingdao China
4 shared publicationsNan Zhou
Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, China
3 shared publications- Xia Zhang
Qingdao Medical College of Qingdao University, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
3 shared publications Bao Xue
Neuropsychiatry Research Institute, The Affiliated Hospital of Qingdao University, Qingdao, China
2 shared publicationsHuamin Xu
Neuropsychiatry Research Institute, The Affiliated Hospital of Qingdao University, Qingdao, China
2 shared publications
Latest Publications
- 12 May 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 823, 153932
Medial prefrontal cortex in chronic pain: Integrating circuit, epigenetics, and molecular insights
- 12 May 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 823, 153932
Medial prefrontal cortex in chronic pain: Integrating circuit, epigenetics, and molecular insights
- Open Access
- 28 February 2026
- Published by Wiley in Advanced Science
- Vol. 13 (29) , e20530
PVN CRF Neurons Regulate Migraine‐Like Allodynia by Activating CRFR2 on Spinal Trigeminal Caudalis Glutamatergic Neurons
Migraine is a prevalent and debilitating neurological disorder with poorly understood neural mechanisms. Here, we characterize a hypothalamic‐trigeminal pathway involved in the regulation of migraine‐like allodynia. Using a combination of monosynaptic circuit, fiber photometry‐based calcium imaging, and behavioral assays in a nitroglycerin (NTG)‐induced murine model, we observed hyperactivity in corticotropin‐releasing factor (CRF)‐expressing neurons within the hypothalamic paraventricular nucleus (PVN). Activation or inhibition of PVN CRF neurons mimicked or blocked migraine‐like allodynia, respectively. These PVN CRF neurons modulated migraine‐like allodynia by exciting glutamatergic neurons in the spinal trigeminal nucleus caudalis (SP5C). Furthermore, employing a CRF neurotransmitter fluorescent sensor, neuropharmacology, and electrophysiological recordings, we revealed that PVN CRF neurons excessively release CRF neuropeptides onto SP5C Glu neurons during migraine‐like conditions. This led to hyperactivation of corticotropin‐releasing factor receptor type 2 (CRFR2), but not type 1 (CRFR1), resulting in hyperalgesia. Blockade of CRFR2 within the SP5C significantly alleviated migraine‐like allodynia. Complementing these findings, clinical functional magnetic resonance imaging (fMRI) of migraine patients indicated structural and functional alterations in PVN and SP5C regions associated with this pathway. Collectively, our results uncover a previously unappreciated PVN CRF ‐SP5C Glu pathway in migraine‐like allodynia, providing novel insights into the neurobiology of migraine and identifying potential therapeutic targets.
- 28 February 2026
- Published by Wiley in Advanced Science
- Vol. 13 (29) , e20530
Open AccessPVN CRF Neurons Regulate Migraine‐Like Allodynia by Activating CRFR2 on Spinal Trigeminal Caudalis Glutamatergic Neurons
Migraine is a prevalent and debilitating neurological disorder with poorly understood neural mechanisms. Here, we characterize a hypothalamic‐trigeminal pathway involved in the regulation of migraine‐like allodynia. Using a combination of monosynaptic circuit, fiber photometry‐based calcium imaging, and behavioral assays in a nitroglycerin (NTG)‐induced murine model, we observed hyperactivity in corticotropin‐releasing factor (CRF)‐expressing neurons within the hypothalamic paraventricular nucleus (PVN). Activation or inhibition of PVN CRF neurons mimicked or blocked migraine‐like allodynia, respectively. These PVN CRF neurons modulated migraine‐like allodynia by exciting glutamatergic neurons in the spinal trigeminal nucleus caudalis (SP5C). Furthermore, employing a CRF neurotransmitter fluorescent sensor, neuropharmacology, and electrophysiological recordings, we revealed that PVN CRF neurons excessively release CRF neuropeptides onto SP5C Glu neurons during migraine‐like conditions. This led to hyperactivation of corticotropin‐releasing factor receptor type 2 (CRFR2), but not type 1 (CRFR1), resulting in hyperalgesia. Blockade of CRFR2 within the SP5C significantly alleviated migraine‐like allodynia. Complementing these findings, clinical functional magnetic resonance imaging (fMRI) of migraine patients indicated structural and functional alterations in PVN and SP5C regions associated with this pathway. Collectively, our results uncover a previously unappreciated PVN CRF ‐SP5C Glu pathway in migraine‐like allodynia, providing novel insights into the neurobiology of migraine and identifying potential therapeutic targets.
- Open Access
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1532078
Input–output organization of the mouse BLA-projecting IL neurons
Introduction: The infralimbic cortex (IL), a critical subregion within the ventromedial prefrontal cortex (vmPFC), modulates emotion, memory, and social functions via robust projections to the basolateral amygdala (BLA). However, the afferent brain regions that innervate BLA-projecting IL neurons (IL-BLA PNs) and their efferent targets have not been systematically characterized.Methods: We employed tracing techniques integrating adeno-associated virus (AAV) and monosynaptic rabies to systematically investigate the presynaptic inputs and axonal outputs of IL-BLA PNs.Results: Our findings revealed widespread synaptic inputs to IL-BLA PNs from subcortical areas, with the strongest inputs originating from the dorsomedial thalamus (MD) and anterior medial thalamus (AM) in the thalamic region, as well as from the ventral hippocampus (vHPC) and piriform cortex (Pir) in the limbic system. Sparse labeling of the virus demonstrated that IL-BLA PNs collateralize to innervate various subcortical regions, including the horizontal diagonal band (HDB), lateral preoptic area (LPO), ventral pallidum (VP), and lateral hypothalamus (LH).Discussion: This work establishes essential theoretical frameworks for the functional investigation and targeted intervention in neurological disorders.
- 19 February 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1532078
Open AccessInput–output organization of the mouse BLA-projecting IL neurons
Introduction: The infralimbic cortex (IL), a critical subregion within the ventromedial prefrontal cortex (vmPFC), modulates emotion, memory, and social functions via robust projections to the basolateral amygdala (BLA). However, the afferent brain regions that innervate BLA-projecting IL neurons (IL-BLA PNs) and their efferent targets have not been systematically characterized.Methods: We employed tracing techniques integrating adeno-associated virus (AAV) and monosynaptic rabies to systematically investigate the presynaptic inputs and axonal outputs of IL-BLA PNs.Results: Our findings revealed widespread synaptic inputs to IL-BLA PNs from subcortical areas, with the strongest inputs originating from the dorsomedial thalamus (MD) and anterior medial thalamus (AM) in the thalamic region, as well as from the ventral hippocampus (vHPC) and piriform cortex (Pir) in the limbic system. Sparse labeling of the virus demonstrated that IL-BLA PNs collateralize to innervate various subcortical regions, including the horizontal diagonal band (HDB), lateral preoptic area (LPO), ventral pallidum (VP), and lateral hypothalamus (LH).Discussion: This work establishes essential theoretical frameworks for the functional investigation and targeted intervention in neurological disorders.
- Open Access
- 30 January 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (2) , 115253
Pde4b-regulated cAMP signaling pathway in the AUDGABA-S1TrSst circuit underlies acute-stress-induced anxiety-like behavior
- 30 January 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (2) , 115253
Open AccessPde4b-regulated cAMP signaling pathway in the AUDGABA-S1TrSst circuit underlies acute-stress-induced anxiety-like behavior
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
Endocannabinoids Block Headache and Anxiety Comorbidity via Two-Pronged Anterior Insular Projections
The mechanism of and effective treatment for the headache, with the global prevalence of 52%, and its common anxiety comorbidity remain elusive. Here, we found that chronic isosorbide dinitrate (ISDN) injections induce c-fos expression in the anterior insula (AI), prelimbic cortex (PrL), and oval nucleus of the bed nucleus of the stria terminalis (ovBNST), suggesting their contributions to headache and anxiety comorbidity. This hypothesis is substantiated by our findings that chronic ISDN injection-induced headache and anxiety are blocked by inhibition of ventral AI (vAI)-PrL and dorsal AI (dAI)-ovBNST circuits, respectively. Headache and anxiety stimuli in chronic ISDN-injected mice markedly increase endocannabinoid (eCB) release at both glutamatergic vAI-PrL synapses and dAI-ovBNST synapses, indicating the role of eCB signaling in modulating headache and anxiety. Indeed, presynaptic knockdown of eCB hydrolase or presynaptic activation of cannabinoid type 1 receptors (CB1Rs) in vAI-PrL and dAI-ovBNST circuits separately alleviates headache and anxiety. A systemic application of eCB degradation enzyme inhibitors blocks chronic ISDN-induced headache and anxiety comorbidity, which are separately blocked by CB1R antagonist application in PrLs and ovBNSTs. Our findings reveal divergent counteracting effects of elevated eCB signaling in vAI-PrL and dAI-ovBNST circuits on comorbid headache and anxiety.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
Open AccessEndocannabinoids Block Headache and Anxiety Comorbidity via Two-Pronged Anterior Insular Projections
The mechanism of and effective treatment for the headache, with the global prevalence of 52%, and its common anxiety comorbidity remain elusive. Here, we found that chronic isosorbide dinitrate (ISDN) injections induce c-fos expression in the anterior insula (AI), prelimbic cortex (PrL), and oval nucleus of the bed nucleus of the stria terminalis (ovBNST), suggesting their contributions to headache and anxiety comorbidity. This hypothesis is substantiated by our findings that chronic ISDN injection-induced headache and anxiety are blocked by inhibition of ventral AI (vAI)-PrL and dorsal AI (dAI)-ovBNST circuits, respectively. Headache and anxiety stimuli in chronic ISDN-injected mice markedly increase endocannabinoid (eCB) release at both glutamatergic vAI-PrL synapses and dAI-ovBNST synapses, indicating the role of eCB signaling in modulating headache and anxiety. Indeed, presynaptic knockdown of eCB hydrolase or presynaptic activation of cannabinoid type 1 receptors (CB1Rs) in vAI-PrL and dAI-ovBNST circuits separately alleviates headache and anxiety. A systemic application of eCB degradation enzyme inhibitors blocks chronic ISDN-induced headache and anxiety comorbidity, which are separately blocked by CB1R antagonist application in PrLs and ovBNSTs. Our findings reveal divergent counteracting effects of elevated eCB signaling in vAI-PrL and dAI-ovBNST circuits on comorbid headache and anxiety.
- 24 November 2024
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 50 (7) , 1063-1074
Endocannabinoid interference blocks post-global cerebral ischemia depression through prefrontal cortico-amygdala projections
Up to 45% of patients surviving from transient global cerebral ischemia (GCI) after cardiac arrest develop post-global cerebral ischemia depression (PGCID), but how to treat PGCID is clinically unknown. Here we find that cannabinoid type-1 receptor (CB1R) antagonists, CB1R knockout and endocannabinoid (eCB) synthesis inhibition block acute stress-induced PGCID. Application of acute stress to GCI mice increases CB1R activity from ventromedial prefrontal cortical (vmPFC) terminals synapsing with the basolateral amygdala (BLA) neurons, indicating the involvement of increased vmPFC-BLA synaptic eCB signaling in PGCID induction. This idea is supported by findings that optogenetic activation of CB1Rs in vmPFC-BLA projections mimics stress effects to induce PGCID, which is blocked by knock-down of eCB biosynthesis enzyme genes in vmPFC-BLA synapses. Interestingly, GCI mice show decreased mRNA expression of eCB degradation enzymes in vmPFCs without significant changes on mRNA expression of eCB biosynthesis and degradation enzymes in BLA cells. Thus, over-expression of eCB degradation enzymes in vmPFC cells innervating BLA neurons or activation of vmPFC-BLA projections blocks stress effects to induce PGCID. Our findings suggest that decreased eCB degradation and subsequent stress-increased eCB signaling in vmPFC-BLA circuits participate in the mechanism of PGCID, which can be treated clinically by eCB signaling interference systemically or in vmPFC-BLA circuits.
- 24 November 2024
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 50 (7) , 1063-1074
Endocannabinoid interference blocks post-global cerebral ischemia depression through prefrontal cortico-amygdala projections
Up to 45% of patients surviving from transient global cerebral ischemia (GCI) after cardiac arrest develop post-global cerebral ischemia depression (PGCID), but how to treat PGCID is clinically unknown. Here we find that cannabinoid type-1 receptor (CB1R) antagonists, CB1R knockout and endocannabinoid (eCB) synthesis inhibition block acute stress-induced PGCID. Application of acute stress to GCI mice increases CB1R activity from ventromedial prefrontal cortical (vmPFC) terminals synapsing with the basolateral amygdala (BLA) neurons, indicating the involvement of increased vmPFC-BLA synaptic eCB signaling in PGCID induction. This idea is supported by findings that optogenetic activation of CB1Rs in vmPFC-BLA projections mimics stress effects to induce PGCID, which is blocked by knock-down of eCB biosynthesis enzyme genes in vmPFC-BLA synapses. Interestingly, GCI mice show decreased mRNA expression of eCB degradation enzymes in vmPFCs without significant changes on mRNA expression of eCB biosynthesis and degradation enzymes in BLA cells. Thus, over-expression of eCB degradation enzymes in vmPFC cells innervating BLA neurons or activation of vmPFC-BLA projections blocks stress effects to induce PGCID. Our findings suggest that decreased eCB degradation and subsequent stress-increased eCB signaling in vmPFC-BLA circuits participate in the mechanism of PGCID, which can be treated clinically by eCB signaling interference systemically or in vmPFC-BLA circuits.
- 31 March 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (7) , 1191
Correction to: Chromatin Remodeling Factor SMARCA5 is Essential for Hippocampal Memory Maintenance via Metabolic Pathways in Mice
- 31 March 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (7) , 1191
Correction to: Chromatin Remodeling Factor SMARCA5 is Essential for Hippocampal Memory Maintenance via Metabolic Pathways in Mice
- 18 February 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (7) , 1087-1104
Chromatin Remodeling Factor SMARCA5 is Essential for Hippocampal Memory Maintenance via Metabolic Pathways in Mice
Gene transcription and new protein synthesis regulated by epigenetics play integral roles in the formation of new memories. However, as an important part of epigenetics, the function of chromatin remodeling in learning and memory has been less studied. Here, we showed that SMARCA5 (SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5), a critical chromatin remodeler, was responsible for hippocampus-dependent memory maintenance and neurogenesis. Using proteomics analysis, we found protein expression changes in the hippocampal dentate gyrus (DG) after the knockdown of SMARCA5 during contextual fear conditioning (CFC) memory maintenance in mice. Moreover, SMARCA5 was revealed to participate in CFC memory maintenance via modulating the proteins of metabolic pathways such as nucleoside diphosphate kinase-3 (NME3) and aminoacylase 1 (ACY1). This work is the first to describe the role of SMARCA5 in memory maintenance and to demonstrate the involvement of metabolic pathways regulated by SMARCA5 in learning and memory.
- 18 February 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 39 (7) , 1087-1104
Chromatin Remodeling Factor SMARCA5 is Essential for Hippocampal Memory Maintenance via Metabolic Pathways in Mice
Gene transcription and new protein synthesis regulated by epigenetics play integral roles in the formation of new memories. However, as an important part of epigenetics, the function of chromatin remodeling in learning and memory has been less studied. Here, we showed that SMARCA5 (SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5), a critical chromatin remodeler, was responsible for hippocampus-dependent memory maintenance and neurogenesis. Using proteomics analysis, we found protein expression changes in the hippocampal dentate gyrus (DG) after the knockdown of SMARCA5 during contextual fear conditioning (CFC) memory maintenance in mice. Moreover, SMARCA5 was revealed to participate in CFC memory maintenance via modulating the proteins of metabolic pathways such as nucleoside diphosphate kinase-3 (NME3) and aminoacylase 1 (ACY1). This work is the first to describe the role of SMARCA5 in memory maintenance and to demonstrate the involvement of metabolic pathways regulated by SMARCA5 in learning and memory.
- 27 June 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (6) , 3026-3042
A role of prefrontal cortico-hypothalamic projections in wake promotion
Ventromedial prefrontal cortex (vmPFC) processes many critical brain functions, such as decision-making, value-coding, thinking, and emotional arousal/recognition, but whether vmPFC plays a role in sleep–wake promotion circuitry is still unclear. Here, we find that photoactivation of dorsomedial hypothalamus (DMH)-projecting vmPFC neurons, their terminals, or their postsynaptic DMH neurons rapidly switches non-rapid eye movement (NREM) but not rapid eye movement sleep to wakefulness, which is blocked by photoinhibition of DMH outputs in lateral hypothalamus (LHs). Chemoactivation of DMH glutamatergic but not GABAergic neurons innervated by vmPFC promotes wakefulness and suppresses NREM sleep, whereas chemoinhibition of vmPFC projections in DMH produces opposite effects. DMH-projecting vmPFC neurons are inhibited during NREM sleep and activated during wakefulness. Thus, vmPFC neurons innervating DMH likely represent the first identified set of cerebral cortical neurons for promotion of physiological wakefulness and suppression of NREM sleep.
- 27 June 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 33 (6) , 3026-3042
A role of prefrontal cortico-hypothalamic projections in wake promotion
Ventromedial prefrontal cortex (vmPFC) processes many critical brain functions, such as decision-making, value-coding, thinking, and emotional arousal/recognition, but whether vmPFC plays a role in sleep–wake promotion circuitry is still unclear. Here, we find that photoactivation of dorsomedial hypothalamus (DMH)-projecting vmPFC neurons, their terminals, or their postsynaptic DMH neurons rapidly switches non-rapid eye movement (NREM) but not rapid eye movement sleep to wakefulness, which is blocked by photoinhibition of DMH outputs in lateral hypothalamus (LHs). Chemoactivation of DMH glutamatergic but not GABAergic neurons innervated by vmPFC promotes wakefulness and suppresses NREM sleep, whereas chemoinhibition of vmPFC projections in DMH produces opposite effects. DMH-projecting vmPFC neurons are inhibited during NREM sleep and activated during wakefulness. Thus, vmPFC neurons innervating DMH likely represent the first identified set of cerebral cortical neurons for promotion of physiological wakefulness and suppression of NREM sleep.
- 21 January 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 32 (21) , 4763-4781
miRNA-126a-3p participates in hippocampal memory via alzheimer’s disease-related proteins
Memory formation and consolidation necessitate gene expression and new protein synthesis. MicroRNAs (miRNAs), a family of small noncoding RNAs that inhibit target gene mRNA expression, are involved in new memory formation. In this study, elevated miR-126a-3p (miR-126) levels were found to contribute to the consolidation of contextual fear memory. Using different commonly mined algorithms and luciferase reporter assay, we found two Alzheimer’s disease (AD)-related proteins, namely EFHD2 and BACE1, but not ADAM9, were the targets downregulated by miR-126 after CFC training. Moreover, we indicated that upregulated miR-126 could promote the formation of contextual fear memory by modulating its target EFHD2. Finally, we demonstrated that miR-126 overexpression in dentate gyrus of hippocampus could reduce Aβ plaque area and neuroinflammation, as well as rescue the hippocampal memory deficits in APP/PS1 mice. This study adds to the growing body of evidence for the role of miRNAs in memory formation and demonstrates the implication of EFHD2 protein regulated by miR-126 in the adult brain.
- 21 January 2022
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 32 (21) , 4763-4781
miRNA-126a-3p participates in hippocampal memory via alzheimer’s disease-related proteins
Memory formation and consolidation necessitate gene expression and new protein synthesis. MicroRNAs (miRNAs), a family of small noncoding RNAs that inhibit target gene mRNA expression, are involved in new memory formation. In this study, elevated miR-126a-3p (miR-126) levels were found to contribute to the consolidation of contextual fear memory. Using different commonly mined algorithms and luciferase reporter assay, we found two Alzheimer’s disease (AD)-related proteins, namely EFHD2 and BACE1, but not ADAM9, were the targets downregulated by miR-126 after CFC training. Moreover, we indicated that upregulated miR-126 could promote the formation of contextual fear memory by modulating its target EFHD2. Finally, we demonstrated that miR-126 overexpression in dentate gyrus of hippocampus could reduce Aβ plaque area and neuroinflammation, as well as rescue the hippocampal memory deficits in APP/PS1 mice. This study adds to the growing body of evidence for the role of miRNAs in memory formation and demonstrates the implication of EFHD2 protein regulated by miR-126 in the adult brain.